Open access · US-GOV
via ClinicalTrials.gov Clinical trial
PatientSpot Formerly Known as ArthritisPower
Authors not listed
Global Healthy Living Foundation · 2015
Abstract
Patient Power is a patient research network and database (registry) to collect prospective information about demographics, self-reported diagnoses and medications, and willingness to participate in research from participants with rheumatoid arthritis (RA), spondyloarthritis (SpA), other musculoskeletal conditions, chronic neurological conditions like migraine, chronic pulmonary conditions like Chronic Obstructive Pulmonary Disease (COPD), asthma, autoimmune dermatological conditions such as psoriasis, and other chronic inflammatory or immune-mediated conditions. In addition, since patients with chronic conditions often have other co-morbidities like cardiovascular health and obesity-related metabolic disorders, these conditions will also be included. Participants will provide information from their smartphones or personal computers. The information will be used by researchers and clinicians to help patients and their providers make better, more informed decisions about treatment of chronic conditions.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-26 MST
Cite this
APA
Anonymous. (2015). PatientSpot Formerly Known as ArthritisPower. <em>Global Healthy Living Foundation</em>. https://clinicaltrials.gov/study/NCT03840928
Vancouver
Anonymous. PatientSpot Formerly Known as ArthritisPower. Global Healthy Living Foundation. 2015.
BibTeX
@misc{anon2015Patien,
title = {PatientSpot Formerly Known as ArthritisPower},
author = {Anonymous},
journal = {Global Healthy Living Foundation},
year = {2015},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2012
Open access · OA
Oxidative stress and pulmonary fibrosis
British Journal of Hospital Medicine 2018
Citation only
The pulmonary rehabilitation regimen: a treatment for frailty and ‘inflammaging’?
中国综合临床 2014
Citation only
Effect of inflammatory biomarkers on death of patients with chronic obstructive pulmonary disease
European Journal of Pharmacology 2024
Citation only
Aging in chronic lung disease: Will anti-aging therapy be the key to the cure?
National Geriatric Hospital 2026
Open access · US-GOV
Frailty in Older Adults With Chronic Obstructive Pulmonary Disease (COPD) and Outcomes of the VIVIFRAIL Program
American Journal of Respiratory and Critical Care Medicine 2007
Preprint · OA